Nuvation Bio Inc Class A — Balance Sheet (NYSE:NUVB) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Total assets 145 M776.15 M672.14 M621.48 M540.63 M Total liabilities 2.8 M30.15 M17.07 M16.36 M76.84 M Total equity 5 M746 M655.08 M605.12 M463.79 M Total liabilities & shareholders' equities 145 M776.15 M672.14 M621.48 M540.63 M Total debt ————— Net debt —————

Haberler

Regenxbio (RGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Tracking David Abrams' Abrams Capital Management Portfolio - Q4 2025 Update

Nuvation Bio, IDH1 mutasyonlu gliom için SIGMA denemesini faz 3’e genişletiyor

Nuvation Bio expands SIGMA trial to phase 3 for IDH1-mutant glioma

Nuvation Bio hissesi, Ibtrozi satış ivmesi sayesinde B.Riley’den Al notunu korudu

Nuvation Bio stock maintains Buy rating at B.Riley on Ibtrozi sales momentum

Nuvation Bio: Rollout Data Of Ibtrozi Support A Modest Buy (NYSE:NUVB)

Truist Securities, Ibtrozi’nin benimsenmesi üzerine Nuvation Bio hisse fiyat hedefini 13 dolara yükseltti

Truist Securities raises Nuvation Bio stock price target to $13 on Ibtrozi uptake

Jones Trading raises Nuvation Bio stock price target to $12 on safusidenib study

Down 24% in 4 Weeks, Here's Why Nuvation Bio (NUVB) Looks Ripe for a Turnaround

H.C. Wainwright, Nuvation Bio için hisse fiyat hedefini 17 dolara düşürdü